Covid19 Clinical Trial
Official title:
Surgery in the Time of COVID-19 Pandemic
| NCT number | NCT04684433 |
| Other study ID # | CHUB-Farid |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | April 14, 2020 |
| Est. completion date | March 15, 2021 |
| Verified date | March 2021 |
| Source | Brugmann University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The ongoing coronavirus disease 2019 (COVID-19) which started in China, was declared on the 11th of March as a global pandemic 2020 by the World Health Organization (WHO). Governments around the world have introduced differing forms of lock downs since the start of the pandemic demanding citizens to confine to their homes and go out only in necessity to minimize exposure to the virus. The response was observed in the emergency departments and the number of patients who presented for non-Covid issues drastically reduced. Hospitals activated their mass casualty management plans and have reorganized and overstretched their capacity to be able to absorb both the influx of patients with the virus and those with other conditions. Part of that reorganization was reducing the surgical activity. The main focus was shifted to patients who are considered urgent and elective surgery were postponed. Hence only surgical emergencies were maintained. Many did not present to the emergency department for fear to contract the virus and from a sense of national and global solidarity against that pandemic. Whereas these measures are essential to prevent the spread of the virus, it may be hypothesized that for non-Covid issues, including surgical emergencies, patients may present late to the emergency department due to fear of contracting the infection in hospital. This would delay their management and lead to a worsened symptomology on presentation requiring a more complex surgical intervention with an increased complication profile. The investigators present initial data from four major hospitals in Belgium, characterizing surgical emergencies that were managed since the start of the pandemic and discuss the repercussion the pandemic has on management of urgent surgical patients and most likely evolution of surgery after the pandemic.
| Status | Completed |
| Enrollment | 707 |
| Est. completion date | March 15, 2021 |
| Est. primary completion date | March 15, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: Patients who had a surgical procedure since the start of the lock down in Belgium due to the COVID19 pandemic (16 of March 2020 to the 12 of April 2020). Exclusion Criteria: None |
| Country | Name | City | State |
|---|---|---|---|
| Belgium | UZ Brussel | Brussel | |
| Belgium | CHU Brugmann | Brussels | |
| Belgium | Erasme | Brussels | |
| Belgium | St Pierre | Brussels |
| Lead Sponsor | Collaborator |
|---|---|
| Brugmann University Hospital |
Belgium,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Surgery code | Type of surgery as defined by the surgery code | 5 minutes | |
| Primary | Urgency | Degree of urgency of the surgery | 5 minutes | |
| Primary | Type of anesthesia | Type of anesthesia | 5 minutes | |
| Primary | Delay between surgery and first symptoms | Delay between surgery and first symptoms | 5 minutes | |
| Primary | Surgery duration | Surgery duration (anesthesia included) | 5 minutes | |
| Primary | Hospital stay (in days) | Hospital stay (in days) | 5 minutes | |
| Primary | Intensive care unit stay (in days) | Intensive care unit stay (in days) | 5 minutes | |
| Primary | Post-op complications | Post-op complications | 5 minutes | |
| Primary | Covid status before surgery | Covid status before surgery (positive=1, negative=0 ) | 5 minutes | |
| Primary | Covid status post-surgery | Covid status post-op (positive=1, negative=0 ) | 5 minutes | |
| Primary | COVID19 Diagnosis by CT scan | COVID19 Diagnosis confirmed by CT scan of the thorax (Yes=1, No=0) | 5 minutes | |
| Primary | COVID19 Diagnosis by swab test | COVID19 Diagnosis by swab test (Yes=1, No=0) | 5 minutes | |
| Primary | COVID 19 Diagnosis by antibody test | COVID 19 Diagnosis by antibody test (Yes=1, No=0) | 5 minutes | |
| Primary | COVID19 symptoms - dry cough | dry cough (Yes=1, No=0) | 5 minutes | |
| Primary | COVID19 symptoms - fever | fever (Yes=1, No=0) | 5 minutes | |
| Primary | COVID19 symptoms - myalgia | myalgia (Yes=1, No=0) | 5 minutes | |
| Primary | COVID19 symptoms - anosmia | anosmia (Yes=1, No=0) | 5 minutes | |
| Primary | COVID19 symptoms -respiratory distress | respiratory distress (Yes=1, No=0) | 5 minutes | |
| Primary | Treatment for COVID19 - Plaquenil | Plaquenil (Yes=1, No=0) | 5 minutes | |
| Primary | Treatment for COVID19 - Antivirals | Antivirals (Yes=1, No=0) | 5 minutes | |
| Primary | Need for intubation | Need for intubation (Yes=1, No=0) | 5 minutes | |
| Primary | Death | Mortality (Yes=1, No=0) | 5 minutes | |
| Secondary | Age | Patient age | 5 minutes | |
| Secondary | Gender | Patient gender | 5 minutes | |
| Secondary | Ethnicity | Patient ethnicity | 5 minutes | |
| Secondary | BMI | Patient Body Mass Index | 5 minutes | |
| Secondary | Comorbidities | Patient comorbidities | 5 minutes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
| Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
| Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
| Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
| Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
| Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
| Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
| Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
| Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
| Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
| Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
| Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
| Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
| Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
| Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
| Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |